SCHEMBL7974256

SCHEMBL7974256

CCCc1nc(O)c2c(ncn2Cc2ccncc2)n1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 1/20 0.40
YTHDC1 Q96MU7 1/20 0.38
HPGD P15428 2/20 0.34
TLR7 Q9NYK1 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 2/20 0.34
PPARG P37231 1/20 0.34
LMNA P02545 2/20 0.33
MAPK1 P28482 2/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KDM4E B2RXH2 3/20 0.33
MET P08581 2/20 0.32
CYP11B1 P15538 1/20 0.32
HSD17B13 Q7Z5P4 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989407 0.88 HPGD (0.44) CNOT7HPGDSMN1; SMN2ALDH1A1POLB
SCHEMBL7989377 0.87 LMNA (0.44) HPGDTLR7SMN1; SMN2ALDH1A1LMNA
SCHEMBL7988957 0.86 MET (0.45) HPGDTLR7SMN1; SMN2ALDH1A1LMNA
SCHEMBL7985861 0.85 CNOT7 (0.44) CNOT7TLR7SMN1; SMN2ALDH1A1PPARG
SCHEMBL7985733 0.84 MEN1 (0.47) YTHDC1HPGDSMN1; SMN2ALDH1A1PPARG
SCHEMBL7984746 0.84 ABCC8 (0.46) HPGDTLR7SMN1; SMN2ALDH1A1MET
SCHEMBL7987609 0.82 PDE4A (0.43) HPGDSMN1; SMN2ALDH1A1POLBCYP11B1
SCHEMBL7991724 0.82 SMN1; SMN2 (0.47) YTHDC1SMN1; SMN2MAPK1HTTKDM4E
SCHEMBL7989566 0.81 HPGD (0.41) CNOT7HPGDSMN1; SMN2ALDH1A1POLB
SCHEMBL7988660 0.81 CYP11B1 (0.49) HPGDSMN1; SMN2ALDH1A1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed